Search results for "Prostate cancer"
NAFLD treatment starts with weight loss, then other modes
Nonalcoholic fatty liver disease (NAFLD), which accounts for 30% to 40% of chronic liver disease in the U.S. today, is the hepatic manifestation of the metabolic syndrome and is associated with sleep apnea, cardiovascular disease, and diabetes.
https://immattersacp.org/archives/2016/07/NAFLD.htm
1 Jul 2016
Decision aids integral to shared decision making
When used properly and in the correct situation, decision aids save time and costs by better meeting patient needs and increasing adherence.
https://immattersacp.org/archives/2019/05/decision-aids-integral-to-shared-decision-making.htm
1 May 2019
Information plus documentation a must for informed consent
Documentation of informed consent is an important deterrent to malpractice and negligence claims. One physician describes how his informed consent process was the deciding factor in a missed case of prostate cancer, and outlines how any physician can accomplish it.
https://immattersacp.org/archives/2012/01/consent.htm
1 Jan 2012
MKSAP Quiz: Exacerbations of heart failure
A 68-year-old man is evaluated at a follow-up appointment. He has a 7-year history of heart failure secondary to ischemic cardiomyopathy. Over the past 6 months, he has had three hospitalizations for exacerbations of his heart failure. He currently has exertional dyspnea while getting dressed, and his maximal activity level is limited to riding to the store with his wife but staying in the car. Following a physical exam and lab studies, what is the most appropriate management?
https://immattersacp.org/weekly/archives/2018/03/13/3.htm
13 Mar 2018
ACP convenes, in person and virtually, for Internal Medicine Meeting 2022
This month's issue considers coverage of Internal Medicine Meeting 2022, Leadership Day in Washington, D.C., and ACP's ninth COVID-19 forum.
https://immattersacp.org/archives/2022/07/acp-convenes-in-person-and-virtually-for-internal-medicine-meeting-2022.htm
1 Jul 2022
Task Force draft recommendation leaves PSA screening choice up to patients
Clinicians should talk to men ages 55 to 69 about the potential benefits and harms of screening, according to the U.S. Preventive Services Task Force. For men ages 70 years and older, the potential benefits of prostate-specific antigen (PSA)-based screening do not outweigh the harms, the Task Force said.
https://immattersacp.org/weekly/archives/2017/04/18/1.htm
18 Apr 2017
Changes to contraindication for statins in pregnancy
This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2021/09/changes-to-contraindication-for-statins-in-pregnancy.htm
1 Sep 2021
Discussion of stopping cancer screening may go best when focused on lack of benefit instead of limited life expectancy
Survey respondents' most preferred phrase was “your other health issues should take priority”; the least preferred choice was “the doctor does not give an explanation.”
https://immattersacp.org/weekly/archives/2018/07/03/4.htm
3 Jul 2018
New warning on NSAIDs; drug approved for flu exposures
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2021/01/new-warning-on-nsaids-drug-approved-for-flu-exposures.htm
1 Jan 2021
Points to consider in palliative care
An integrated model of curative and palliative care may lead some physicians to reconsider their role in care at the end of life.
https://immattersacp.org/archives/2018/07/points-to-consider-in-palliative-care.htm
1 Jul 2018